What is City Therapeutics, Inc. Common Stock's share price today?
City Therapeutics, Inc. Common Stock (CTY) share price today is $17.53 as of November 18, 2026 at 2:29 AM IST. The stock touched a day high of $17.63 and a day low of $16.48.What exchange does City Therapeutics, Inc. Common Stock stock trade on, and under what ticker symbol?
City Therapeutics, Inc. Common Stock stock trades on NASDAQ under the ticker symbol CTY.What is City Therapeutics, Inc. Common Stock's market capitalization?
City Therapeutics, Inc. Common Stock's market capitalization is $911.01M as of November 18, 2026 at 2:29 AM IST.What is City Therapeutics, Inc. Common Stock's price-to-earnings (P/E) ratio?
City Therapeutics, Inc. Common Stock's price-to-earnings (P/E) ratio is N/A as of November 17, 2026.What is City Therapeutics, Inc. Common Stock's price-to-book (P/B) ratio?
City Therapeutics, Inc. Common Stock's price-to-book (P/B) ratio is 0 as of November 17, 2026.Can Indian investors buy City Therapeutics, Inc. Common Stock shares?
Yes, You can buy City Therapeutics, Inc. Common Stock shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in City Therapeutics, Inc. Common Stock shares from India?
Indian investors can buy City Therapeutics, Inc. Common Stock shares in three steps: 1. Search City Therapeutics, Inc. Common Stock on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from City Therapeutics, Inc. Common Stock shares for Indian investors?
Since City Therapeutics, Inc. Common Stock trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in City Therapeutics, Inc. Common Stock shares via Tickertape?
Indian investors can start investing in City Therapeutics, Inc. Common Stock (CTY) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.5702 shares at the current price of $17.53.
$
₹
$17.533.28% (+0.55)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
—
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
0
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$-2.53
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Based on 3 analysts reports
Buy3 analysts
Hold0 analyst
Sell0 analyst
Price Upside
+113.33%
Earnings Growth
—
Rev. Growth
+62.96%
Company Profile
Company Profile
Forecast
Forecast
Price
Revenue
Earnings
Price Forecast
Price Forecast
2026
Current$17.5Baseline
Analyst Target - 1 year
Target$37.33+113.33%
All values in $
2026
Current$17.5Baseline
Analyst Target - 1 year
Target$37.33+113.33%
All values in $
Revenue Forecast
Revenue Forecast
2025
Current$0.01Baseline
Forecast for Dec 2026
High$0.03+121.21%
Average$0.02+62.96%
Low$0.01-1.19%
All values in $ Billion
2025
Current$0.01Baseline
Forecast for Dec 2026
High$0.03+121.21%
Average$0.02+62.96%
Low$0.01-1.19%
All values in $ Billion
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View
Q1 2020
Q2 2020
Q4 2025
Q2 2026
Revenue
Net Income
| Financial Year | Q3 2018 | Q4 2018 | Q1 2019 | Q2 2019 | Q3 2019 | Q4 2019 | Q1 2020 | Q2 2020 | Q4 2025 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2.14 | 2.11 | 2.05 | 2.05 | 2.03 | 2.01 | 1.91 | 0.52 | - | - |
| Gross Profit | 1.45 | 1.45 | 1.44 | 1.46 | 1.40 | 1.39 | 1.44 | 0.03 | - | - |
| Net Income | 0.45 | 0.40 | 0.48 | 0.47 | 0.47 | 0.38 | 0.50 | 0.43 | - | - |
| Net Profit Margin | 21.07% | 19.16% | 23.69% | 23.25% | 23.39% | 19.18% | 26.22% | 82.06% | - | - |
Peers
Price Comparison
Compare CTY with any stocks or ETF